You are here
- Home
Total number of clinical trials
-
expand
The Predictors for asthma control by stepwise treatment during 6 months in Korean elderly
- Study Id
- NIS-RKR-XXX-2011/1
- Disease
- asthma
- Drug Name
- non drug study (respiratory)
- Study Name
- NIS-RKR-XXX-2011/1
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, Single Centre, Open, Partly Randomised, Crossover Study in Healthy Subjects to Evaluate AZD5423 Absolute Pulmonary Bioavailability when Administered Inhaled via a New Dry Powder Inhaler, Turbuhaler, Spira nebulizer and I-neb AAD system
- Study Id
- D2340C00012
- Disease
- pharmacokinetics
- Drug Name
- AZD5423
- Study Name
- D2340C00012
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent
- Study Id
- NIS-OKR-CAS-2010/1
- Disease
- prostate cancer
- Drug Name
- non drug study (oncology)
- Study Name
- NIS-OKR-CAS-2010/1
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of AZD4547 in Japanese Patients with Advanced Solid Malignancies
- Study Id
- D2610C00002
- Drug Name
- AZD4547
- Study Name
- D2610C00002
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Observational study to understand patients’ and physicians’ attitudes to Statins in Turkey
- Study Id
- NIS-CTR-XXX-2012/1
- Disease
- hypercholesterolaemia
- Drug Name
- non drug study (cardiovascular)
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Efficacy and tolerability study of Symbicort Turbuhaler(160/4.5μg/inhalation,2inhalations twice daily) added to Atrovent (20μg/inhalation, 2 inhalations 4 times daily)+theophylline SR(0.1g/tablet,1 tablet p.o. twice daily) compared with Atrovent+theophylline SR in severe COPD patients
- Study Id
- D589BL00022
- Disease
- chronic obstructive pulmonary disease
- Drug Name
- Symbicort Turbuhaler
- Study Name
- SECURE 2
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, Open-label, Multicentre, Dose Escalation Study to Assess the Safety and Tolerability, and Pharmacokinetics of AZD1480 in Asian Patients with Advanced Solid Malignancies and Asian Patients with Child-Pugh A to B7 Advanced Hepatocellular Carcinoma (HCC) in the escalation phase, EGFR or ROS mutant NSCLC and non-smokers with lung metastasis and gastric cancer and solid tumour with biopsy available in the expansion phase.
- Study Id
- D1060C00004
- Disease
- hepatocellular carcinoma
- Drug Name
- AZD1480
- Study Name
- D1060C00004
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
An Open-label, Single-center, 2-Part, Randomized Study to Assess the Pharmacokinetics of R406 in Healthy Subjects when Fostamatinib 150 mg is Administered Alone in Fed and Fasted state and in Combination with Ranitidine in Fasted State, and to Assess the Relative Bioavailability of Process Variants of Tablets
- Study Id
- D4300C00019
- Disease
- pharmacokinetics
- Drug Name
- Fostamatinib Disodium
- Study Name
- D4300C00019
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A Phase I, Single-centre, Open-label, Partly Randomised, Cross-over Single Dose Study in Healthy Volunteers to Evaluate the Absolute Pulmonary Bioavailability of AZD8683 when Administered Inhaled via a New Dry Powder Inhaler and via Turbuhaler™
- Study Id
- D1883C00008
- Disease
- pharmacokinetics
- Drug Name
- AZD8683
- Study Name
- D1883C00008
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A randomised, double-blind placebo- and active-controlled, multi-centre, 6-way cross-over, single-dose phase IIa study to investigate the bronchodilatory and systemic effects of 4 different doses of inhaled AZD8683 in patients with Chronic Obstructive Pulmonary Disease (COPD)
- Study Id
- D1883C00007
- Disease
- chronic obstructive pulmonary disease
- Drug Name
- AZD8683
- Study Name
- D1883C00007
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
